[Synthesis of 14C-anpirtoline]

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.

Archiv der Pharmazie·2002

1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.

Archiv der Pharmazie·2001

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.

Archiv der Pharmazie·2001

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.

Archiv der Pharmazie·2001

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.

Journal of cancer research and clinical oncology·2000

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.

Archiv der Pharmazie·2000

Synthesis and Characterization of Tritium-Labeled Neuropeptide Y Y5 Receptor Ligands Derived From CGP71683A.

Archiv der Pharmazie·2026

Olikomycin A Disrupts Gram-Positive Bacterial Membranes Through Calcium-Dependent Binding to Phosphatidylglycerol.

Archiv der Pharmazie·2026

Venom-Derived Peptides in Breast Cancer: Pharmacological Mechanisms and Medicinal Chemistry-Guided Translational Development.

Archiv der Pharmazie·2026

Cellular and Molecular Mechanisms of Berberine in Cancer Therapy: Recent Advances.

Archiv der Pharmazie·2026

Breaking the Myb-KIX Alliance: Structure-Guided Discovery of Biaryl Hydroxy-Naphthamides as Disruptors of the c-Myb-CBP/p300 KIX Protein-Protein Interaction.

Archiv der Pharmazie·2026

Discovery of VEGFR-2 Inhibitors From Leonurus japonicus via Integrated Genetic Authentication, Molecular Networking, and In Silico Analysis.

Archiv der Pharmazie·2026

Base-promoted dearomatization/1,6-addition of α-haloketones: synthesis of α-azido-α,α-diaryl ketones.

Chemical communications (Cambridge, England)·2026

Enantioselective Access to Trifluoromethylated Spirocyclopropyl Heterocycles.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Organocatalytic Enantioselective Electrophilic C-H Sulfenylation of Arenes.

Accounts of chemical research·2026

Palladium-Catalyzed Fluoroallylation of Aldimine Esters With gem-Difluorocyclopropanes: Synthesis of Fluorinated α-Amino Acid Derivatives.

Chemistry, an Asian journal·2026

Correction: Imine-anion-mediated alkoxy-group-elimination-type SNAr reaction: an efficient synthetic route to phenanthridines.

Chemical communications (Cambridge, England)·2026

Mechanochemical three-component radical sulfonamidation enabled by copper catalysis.

Chemical communications (Cambridge, England)·2026

Related Experiment Videos

[Synthesis of 14C-anpirtoline]

Related Concept Videos

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.

1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.

Synthesis and Characterization of Tritium-Labeled Neuropeptide Y Y5 Receptor Ligands Derived From CGP71683A.

Olikomycin A Disrupts Gram-Positive Bacterial Membranes Through Calcium-Dependent Binding to Phosphatidylglycerol.

Venom-Derived Peptides in Breast Cancer: Pharmacological Mechanisms and Medicinal Chemistry-Guided Translational Development.

Cellular and Molecular Mechanisms of Berberine in Cancer Therapy: Recent Advances.

Breaking the Myb-KIX Alliance: Structure-Guided Discovery of Biaryl Hydroxy-Naphthamides as Disruptors of the c-Myb-CBP/p300 KIX Protein-Protein Interaction.

Discovery of VEGFR-2 Inhibitors From Leonurus japonicus via Integrated Genetic Authentication, Molecular Networking, and In Silico Analysis.

Base-promoted dearomatization/1,6-addition of α-haloketones: synthesis of α-azido-α,α-diaryl ketones.

Enantioselective Access to Trifluoromethylated Spirocyclopropyl Heterocycles.

Organocatalytic Enantioselective Electrophilic C-H Sulfenylation of Arenes.

Palladium-Catalyzed Fluoroallylation of Aldimine Esters With gem-Difluorocyclopropanes: Synthesis of Fluorinated α-Amino Acid Derivatives.

Correction: Imine-anion-mediated alkoxy-group-elimination-type SNAr reaction: an efficient synthetic route to phenanthridines.

Mechanochemical three-component radical sulfonamidation enabled by copper catalysis.

Related Experiment Videos

[Synthesis of 14C-anpirtoline]

Related Concept Videos

Related Articles